Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131978) titled 'A Real-World Study of Coenzyme I for Injection in Cancer Patients at Risk of Heart Problems and Low White Blood Cell Count' on Sept. 8.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Malignant tumors (breast cancer, lymphoma, gastric cancer, colorectal cancer)
cancer therapy-related cardiac dysfunction (CTRCD)
neutropenia
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Coenzyme I for Injection Treatment Group:9000;
Countries of Recruitment:
China
To know more, visit https://www.chi...